In the global pharmaceutical landscape, the efficiency and reliability of supply chains are critical for ensuring patient access to essential medicines. 11-alpha-Hydroxycarvenone, a compound identified by CAS number 192569-17-8, plays a strategically important role in this ecosystem. Its primary function as a key intermediate in the synthesis of Eplerenone, a widely used cardiovascular drug, places it at a crucial juncture in the production process.

The chemical composition of 11-alpha-Hydroxycarvenone, with its molecular formula C22H28O4, and its physical form as a yellow crystalline solid, are well-defined. However, its true value lies in its high purity, typically required to be ≥99%, for its intended pharmaceutical applications. The 11-alpha-Hydroxycarvenone synthesis process must be meticulously controlled to achieve this purity, minimizing potential contaminants that could affect the downstream production of Eplerenone. NINGBO INNO PHARMCHEM CO.,LTD. invests in advanced manufacturing techniques to meet these exacting standards.

For pharmaceutical companies, sourcing intermediates like 11-alpha-Hydroxycarvenone is a strategic decision. It involves not only identifying suppliers who can reliably produce the compound but also ensuring that their quality management systems are robust. The ability to buy 11-alpha-Hydroxycarvenone from a trusted source like NINGBO INNO PHARMCHEM CO.,LTD. contributes significantly to the stability and integrity of the pharmaceutical supply chain, ultimately supporting the consistent availability of vital cardiovascular treatments.